Drug Profile
Research programme: cell-based lung disorder therapeutics - Northern Therapeutics
Alternative Names: Bone marrow derived alveolar progenitor cells - Northern Therapeutics; Cell-based gene therapy - Northern Therapeutics; Cell-based regenerative therapy - Northern therapeuticsLatest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator Northern Therapeutics
- Class Cell therapies; Gene therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Adult respiratory distress syndrome; Cystic fibrosis; Emphysema
Most Recent Events
- 22 Sep 2023 Discontinued - Preclinical for Adult respiratory distress syndrome in Canada (Parenteral)
- 22 Sep 2023 Discontinued - Preclinical for Cystic fibrosis in Canada (Parenteral)
- 22 Sep 2023 Discontinued - Preclinical for Emphysema in Canada (Parenteral)